Skip to main content
. 2021 Mar 4;2021(3):CD010172. doi: 10.1002/14651858.CD010172.pub3

Comparison 1. HFNC versus standard oxygen therapy.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Treatment failure (escalation of respiratory support to NIV, NIPPV or invasive ventilation) 15 3044 Risk Ratio (M‐H, Random, 95% CI) 0.62 [0.45, 0.86]
1.1.1 Post‐extubation respiratory support 11 1912 Risk Ratio (M‐H, Random, 95% CI) 0.50 [0.30, 0.86]
1.1.2 Respiratory support without prior use of mechanical ventilation 4 1132 Risk Ratio (M‐H, Random, 95% CI) 0.85 [0.68, 1.08]
1.2 In‐hospital mortality 11 2673 Risk Ratio (M‐H, Random, 95% CI) 0.96 [0.82, 1.11]
1.3 Important adverse events 5   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.3.1 Pneumonia 4 1057 Risk Ratio (M‐H, Random, 95% CI) 0.72 [0.48, 1.09]
1.3.2 Nasal mucosa or skin trauma 2 617 Risk Ratio (M‐H, Random, 95% CI) 3.66 [0.43, 31.48]
1.4 Length of ICU stay (days) 6 970 Mean Difference (IV, Random, 95% CI) 0.13 [‐0.02, 0.28]
1.5 Short‐term respiratory effects: PaO 2/FiO 2 (mmHg) 5 600 Mean Difference (IV, Random, 95% CI) 10.34 [‐17.31, 38.00]
1.6 Comfort 4   Mean Difference (IV, Random, 95% CI) Subtotals only
1.6.1 Short‐term effect 4 662 Mean Difference (IV, Random, 95% CI) 0.31 [‐0.60, 1.22]
1.6.2 Long‐term effect 2 445 Mean Difference (IV, Random, 95% CI) 0.59 [‐2.29, 3.47]
1.7 Long‐term respiratory effects: PaO 2/FiO 2 (mmHg) 2 195 Mean Difference (IV, Random, 95% CI) 34.28 [‐19.25, 87.80]
1.8 Short‐term and long‐term respiratory effects: PaO 2 (mmHg) 5   Mean Difference (IV, Random, 95% CI) Subtotals only
1.8.1 Short‐term effects 4 415 Mean Difference (IV, Random, 95% CI) 4.92 [‐1.24, 11.07]
1.8.2 Long‐term effects 2 644 Mean Difference (IV, Random, 95% CI) 12.27 [7.51, 17.04]
1.9 Short‐term and long‐term respiratory effects: SpO 2 (%) 5   Mean Difference (IV, Random, 95% CI) Subtotals only
1.9.1 Short‐term effects 5 572 Mean Difference (IV, Random, 95% CI) 0.79 [‐0.29, 1.88]
1.9.2 Long‐term effects 2 445 Mean Difference (IV, Random, 95% CI) 1.28 [0.02, 2.55]
1.10 Short‐term respiratory effects: PaCO 2 (mmHg) 5 755 Mean Difference (IV, Random, 95% CI) ‐1.05 [‐2.24, 0.13]
1.11 Short‐term and long‐term respiratory rate (breaths/min) 9 1608 Mean Difference (IV, Random, 95% CI) ‐2.01 [‐3.19, ‐0.83]
1.11.1 Short‐term effects 8 1017 Mean Difference (IV, Random, 95% CI) ‐2.02 [‐3.66, ‐0.37]
1.11.2 Long‐term effects 4 591 Mean Difference (IV, Random, 95% CI) ‐2.01 [‐4.39, 0.37]
1.12 Length of hospital stay (days) 2 450 Mean Difference (IV, Random, 95% CI) ‐0.11 [‐0.43, 0.20]
1.13 Refusal to continue with treatment 2 560 Risk Ratio (M‐H, Random, 95% CI) 26.89 [3.67, 197.32]